medigraphic.com
ISSN 0016-3813 (Print)

2018, Number 4

<< Back Next >>

Gac Med Mex 2018; 154 (4)

Tendencias de mortalidad y años potenciales de vida perdidos por cáncer de ovario en México, 2000-2014

Sánchez-Barriga JJ

Language: Spanish
References: 22
Page: 438-447
PDF size: 253.29 Kb.


ABSTRACT

Introduction: In Mexico, ovarian cancer accounting for 5.3% of cancer diagnoses in all age groups and 21% of gynecological cancers and it has had a steady increase in the last three decades. Objective: To determine mortality trends from ovarian cancer and potential years of life lost (PYLL) by state and socioeconomic region of Mexico between 2000 and 2014. Method: Records of ovarian cancer were obtained from the National Institute of Statistics and Geography. ICD-10 codes corresponding to ovarian cancer as the basic cause of death were identified. Mortality rates and YPLL rates were calculated by nationwide, states and socioeconomic region. Results: Between 2000 and 2014, age-adjusted rates per 100,000 women increased from 3.3 to 4.1. The highest mortality rates were identified in region 7, in Chihuahua, Baja California Sur, Colima, Quintana Roo, Zacatecas, Sonora, Coahuila, Aguascalientes and Queretaro. The highest rates of PYLL due to ovarian cancer were recorded in regions 7, 5 and 6, Nayarit, Baja California Sur, Zacatecas, Colima, Tlaxcala, Oaxaca, Quintana Roo, Coahuila, Aguascalientes and Queretaro. Conclusions: Mexico’s socioeconomic region 7 had the highest rates of PYLL and mortality from ovarian cancer.


REFERENCES

  1. Ovarian Cancer 2014 Report. Food, nutrition, physical activity, and the prevention of ovarian cancer. Reino Unido: World Cancer Research Fund/American Institute for Cancer Research; 2014. Disponible en: www. wcrf.org/sites/default/files/Ovarian-Cancer-2014-Report.pdf

  2. Malvezzi M, Carioli G, Rodríguez T, Negri E, La-Vecchia C. Global trends and predictions in ovarian cancer mortality. Ann Oncol. 2016;27:2017-2025.

  3. Rivas-Corchado LM, González-Geroniz M, Hernández-Herrera RJ. Epidemiological profile of ovarian cancer. Ginecol Obstet Mex. 2011; 79:558-564.

  4. Torres-Sánchez LE, Rojas-Martínez R, Escamilla-Núñez C, Vara- Salazar E, Lazcano-Ponce E. Tendencias en la mortalidad por cáncer en México de 1980 a 2011. Salud Publica Mex. 2014;56:473-491.

  5. Instituto Nacional de Estadística y Geografía. Registros administrativos de mortalidad. México: Instituto Nacional de Estadistica y Geografía; 2016. Disponible en: http://www3.inegi.org.mx/sistemas/microdatos/encuestas aspx?c=33398&s=est

  6. World Health Organization. International Statistical Classification of Diseases and Problems Related to Health, 10th review. Ginebra, Suiza: World Health Organization; 1995.

  7. Inskip H, Beral V, Fraser P, Haskey J. Methods for age-adjustment of rates. Stat Med. 1983;2:455-466.

  8. Ahmad OB, Boschi-Pinto C, López AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. En: Global Program me on Evidence for Health Policy Discussion Paper Series no. 31. Ginebra, Suiza: World Health Organization; 1999.

  9. Instituto Nacional de Estadistica y Geografía. Regiones socioeconómicas de México México: Instituto Nacional de Estadistica y Geografía; 2000. Disponible en :http://sc inegi.org.mx/niveles/datosnbi/reg_soc_mexico. pdf

  10. Consejo Nacional de Población. Estimaciones demográficas 1990-2010 y proyecciones de la población 2010-2050. México: Consejo Nacional de Población; 2014. Disponible en. http //www.conapo.gob.mx/es/CONAPO/ Proyecciones_Datos.

  11. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration: principles and methods. Francia: International Agency for Research on Cancer; 1995.

  12. Pan American Health Organization. Techniques to measure the impact of mortality: years of potential life lost. Epidemiological Bulletin. 2003; 24:1-4.

  13. Romeder JM, McWhinnie JR. Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. Int J Epidemiol. 1977;6:143-151.

  14. Hervada-Vidal X, Santiago-Pérez M, Vázquez-Fernández E, Castillo-Salgado C, Loyola-Eñizondo E, Silva-Ayçaguer LC. Epidat 3.0 Programa para análisis epidemiológico de datos tabulados. Rev Esp Salud Publica. 2004;78:277–280.

  15. Hunn J, Rodríguez GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol. 2012;55:3-23.

  16. Walker JL, Powell CB, Chen LM, Carter J, Bae-Jump VL, Parker LP, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121:2108-2120.

  17. Smith ER, Xu XX. Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion. Lancet Oncol. 2008;9:1108-1111.

  18. Song H, Cicek MS, Dicks E, Harrington P, Ramus SJ, Fridley BL, et al. The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Hum Mol Genet. 2014;23:4703-4709.

  19. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14:9-32.

  20. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Informe final de resultados. México: Secretaría de Salud/Instituto Nacional de Salud Pública; 2016.

  21. Kuri-Morales P, Emberson J, Alegre-Díaz J, Tapia-Conyer R, Collins R, Peto R, et al. The prevalence of chronic diseases and major disease risk factors at different ages among 150 000 men and women living in Mexico City: cross-sectional analyses of a prospective study. BMC Public Health. 2009;9:9.

  22. Reynales-Shigematsu L, Valdés-Salgado R, Rodríguez-Bolaños R, Lazcano- Ponce E, Hernández-Ávila M. Encuesta de tabaquismo en jóvenes en México. Análisis descriptivo 2003, 2005, 2006, 2008. México: Instituto Nacional de Salud Pública/Secreataría de Salud/Comisión Nacional contra las Adicciones; 2009.




2020     |     www.medigraphic.com